These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 30299587)

  • 1. Synthesis of Cytokinins via Enzymatic Arsenolysis of Purine Nucleosides.
    Oslovsky VE; Drenichev MS; Alexeev CS; Solyev PN; Esipov RS; Mikhailov SN
    Curr Protoc Nucleic Acid Chem; 2018 Dec; 75(1):e61. PubMed ID: 30299587
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemoenzymatic synthesis of cytokinins from nucleosides: ribose as a blocking group.
    Oslovsky VE; Solyev PN; Polyakov KM; Alexeev CS; Mikhailov SN
    Org Biomol Chem; 2018 Mar; 16(12):2156-2163. PubMed ID: 29520402
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanism of thiol-supported arsenate reduction mediated by phosphorolytic-arsenolytic enzymes: II. Enzymatic formation of arsenylated products susceptible for reduction to arsenite by thiols.
    Gregus Z; Roos G; Geerlings P; Németi B
    Toxicol Sci; 2009 Aug; 110(2):282-92. PubMed ID: 19478237
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Purine nucleoside phosphorylase. Catalytic mechanism and transition-state analysis of the arsenolysis reaction.
    Kline PC; Schramm VL
    Biochemistry; 1993 Dec; 32(48):13212-9. PubMed ID: 8241176
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Arsenate and phosphate as nucleophiles at the transition states of human purine nucleoside phosphorylase.
    Silva RG; Hirschi JS; Ghanem M; Murkin AS; Schramm VL
    Biochemistry; 2011 Apr; 50(13):2701-9. PubMed ID: 21348499
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Purine nucleoside phosphorylase as a cytosolic arsenate reductase.
    Gregus Z; Németi B
    Toxicol Sci; 2002 Nov; 70(1):13-9. PubMed ID: 12388830
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Purine nucleoside phosphorylase. Inosine hydrolysis, tight binding of the hypoxanthine intermediate, and third-the-sites reactivity.
    Kline PC; Schramm VL
    Biochemistry; 1992 Jul; 31(26):5964-73. PubMed ID: 1627539
    [TBL] [Abstract][Full Text] [Related]  

  • 8. C(2')-substituted purine nucleoside analogs. Interactions with adenosine deaminase and purine nucleoside phosphorylase and formation of analog nucleotides.
    Stoeckler JD; Bell CA; Parks RE; Chu CK; Fox JJ; Ikehara M
    Biochem Pharmacol; 1982 May; 31(9):1723-8. PubMed ID: 6809009
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recycling of alpha-D-ribose 1-phosphate for nucleoside interconversion.
    Giorgelli F; Bottai C; Mascia L; Scolozzi C; Camici M; Ipata PL
    Biochim Biophys Acta; 1997 Apr; 1335(1-2):6-22. PubMed ID: 9133638
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanism of thiol-supported arsenate reduction mediated by phosphorolytic-arsenolytic enzymes: I. The role of arsenolysis.
    Németi B; Gregus Z
    Toxicol Sci; 2009 Aug; 110(2):270-81. PubMed ID: 19474219
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Purine nucleoside transport and metabolism in isolated rat jejunum.
    Stow RA; Bronk JR
    J Physiol; 1993 Aug; 468():311-24. PubMed ID: 8254512
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombinant purine nucleoside phosphorylases from thermophiles: preparation, properties and activity towards purine and pyrimidine nucleosides.
    Zhou X; Szeker K; Janocha B; Böhme T; Albrecht D; Mikhailopulo IA; Neubauer P
    FEBS J; 2013 Mar; 280(6):1475-90. PubMed ID: 23332162
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pre-steady-state transition-state analysis of the hydrolytic reaction catalyzed by purine nucleoside phosphorylase.
    Kline PC; Schramm VL
    Biochemistry; 1995 Jan; 34(4):1153-62. PubMed ID: 7827065
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of a new HPLC method using fluorescence detection without derivatization for determining purine nucleoside phosphorylase activity in human plasma.
    Giuliani P; Zuccarini M; Buccella S; Rossini M; D'Alimonte I; Ciccarelli R; Marzo M; Marzo A; Di Iorio P; Caciagli F
    J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Jan; 1009-1010():114-21. PubMed ID: 26720700
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glutathione-dependent reduction of arsenate in human erythrocytes--a process independent of purine nucleoside phosphorylase.
    Németi B; Gregus Z
    Toxicol Sci; 2004 Dec; 82(2):419-28. PubMed ID: 15470234
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ribocation transition state capture and rebound in human purine nucleoside phosphorylase.
    Ghanem M; Murkin AS; Schramm VL
    Chem Biol; 2009 Sep; 16(9):971-9. PubMed ID: 19778725
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transition state analysis for human and Plasmodium falciparum purine nucleoside phosphorylases.
    Lewandowicz A; Schramm VL
    Biochemistry; 2004 Feb; 43(6):1458-68. PubMed ID: 14769022
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glutathione-supported arsenate reduction coupled to arsenolysis catalyzed by ornithine carbamoyl transferase.
    Németi B; Gregus Z
    Toxicol Appl Pharmacol; 2009 Sep; 239(2):154-61. PubMed ID: 19248796
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Computer Simulations Reveal Substrate Specificity of Glycosidic Bond Cleavage in Native and Mutant Human Purine Nucleoside Phosphorylase.
    Isaksen GV; Hopmann KH; Åqvist J; Brandsdal BO
    Biochemistry; 2016 Apr; 55(14):2153-62. PubMed ID: 26985580
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and evaluation of the substrate activity of C-6 substituted purine ribosides with E. coli purine nucleoside phosphorylase: palladium mediated cross-coupling of organozinc halides with 6-chloropurine nucleosides.
    Hassan AE; Abou-Elkhair RA; Riordan JM; Allan PW; Parker WB; Khare R; Waud WR; Montgomery JA; Secrist JA
    Eur J Med Chem; 2012 Jan; 47(1):167-74. PubMed ID: 22112758
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.